Does Rallies show Form 4 insider transactions for TRIN?

Yes. Rallies tracks TRIN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TRIN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TRIN. It does not provide personalized investment advice.

TRIN (Trinity Capital Inc. Common Stock) Stock Analysis - Insider Trades

Trinity Capital Inc. Common Stock (TRIN) is a publicly traded Financial Services sector company. As of May 21, 2026, TRIN trades at $16.87 with a market cap of $1.53B and a P/E ratio of 8.89. TRIN moved +1.63% today. Year to date, TRIN is +9.90%; over the trailing twelve months it is +12.84%. Its 52-week range spans $12.50 to $17.38. Analyst consensus is neutral with an average price target of $16.50. Rallies surfaces TRIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TRIN stock inside the company?

Recent TRIN insider activity includes Estes Ronald E. bought 800, Brown Kyle Steven bought 3.53K, Brown Steve Louis bought 27.11K, Estes Ronald E. bought 500, and Brown Steve Louis bought 1.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TRIN Key Metrics

Key financial metrics for TRIN
Metric	Value
Price	$16.87
Market Cap	$1.53B
P/E Ratio	8.89
EPS	$1.90
Dividend Yield	0.17%
52-Week High	$17.38
52-Week Low	$12.50
Volume	0
Avg Volume	0
Revenue (TTM)	$300.16M
Net Income	$138.35M
Gross Margin	0.00%

Recent TRIN Insider Trades

Estes Ronald E. bought 800 (~$11.33K) on Mar 16, 2026.
Brown Kyle Steven bought 3.53K (~$50.02K) on Mar 16, 2026.
Brown Steve Louis bought 27.11K (~$399.86K) on Mar 12, 2026.
Estes Ronald E. bought 500 (~$7.38K) on Mar 11, 2026.
Brown Steve Louis bought 1.58K (~$23.49K) on Mar 9, 2026.

Latest TRIN News

Trinity Capital Q1 Income Climbs 37.8% to $90.1M, NAV at $13.27 — May 6, 2026
Trinity Capital Commits $30 Million to Iantrek for Ophthalmic Surgery Expansion — Apr 28, 2026
Trinity Capital Pledges $50m Growth Investment in FDA-Cleared Tremor Therapy Maker — Apr 21, 2026
Trinity Capital Originates $395M in Q1 Commitments and Funds $306M Investments — Apr 10, 2026
Trinity Capital Commits $50M to Expand Sage Health’s Senior Care Centers — Mar 27, 2026

TRIN Analyst Consensus

4 analysts cover TRIN: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $16.50.

Common questions about TRIN

Who is trading TRIN stock inside the company?: Recent TRIN insider activity includes Estes Ronald E. bought 800, Brown Kyle Steven bought 3.53K, Brown Steve Louis bought 27.11K, Estes Ronald E. bought 500, and Brown Steve Louis bought 1.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TRIN?: Yes. Rallies tracks TRIN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TRIN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TRIN. It does not provide personalized investment advice.